Pharmaceutical Executive
Company-commissioned report exonerates senior managers, points fingers at sales team
Pharmaceutical Executive-09-13-2006
Pharmaceutical Executive
Drug makers used aggressive contracting to retain marketshare after launch of generic simvastatin
Pharmaceutical Executive
Pricing, marketing cases expected to escalate in the future
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
Report: Richard Pazdur Out as Director of CDER
4
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
5
